9.25
Precedente Chiudi:
$9.52
Aprire:
$9.44
Volume 24 ore:
268.22K
Relative Volume:
0.45
Capitalizzazione di mercato:
$397.54M
Reddito:
$324.01M
Utile/perdita netta:
$-192.37M
Rapporto P/E:
-1.9351
EPS:
-4.78
Flusso di cassa netto:
$-23.46M
1 W Prestazione:
-5.52%
1M Prestazione:
-6.75%
6M Prestazione:
+41.44%
1 anno Prestazione:
+47.76%
Angiodynamic Inc Stock (ANGO) Company Profile
Nome
Angiodynamic Inc
Settore
Industria
Telefono
(518) 798-1215
Indirizzo
14 PLAZA DRIVE, LATHAM
Confronta ANGO con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
ANGO
Angiodynamic Inc
|
9.25 | 397.54M | 324.01M | -192.37M | -23.46M | -4.78 |
![]()
ISRG
Intuitive Surgical Inc
|
468.32 | 175.60B | 8.35B | 2.32B | 1.30B | 6.41 |
![]()
BDX
Becton Dickinson Co
|
196.61 | 59.07B | 20.64B | 1.73B | 2.94B | 6.02 |
![]()
ALC
Alcon Inc
|
91.38 | 44.80B | 9.91B | 1.02B | 665.00M | 2.05 |
![]()
RMD
Resmed Inc
|
210.87 | 31.51B | 4.93B | 1.25B | 1.38B | 8.47 |
![]()
COO
The Cooper Companies, Inc.
|
78.70 | 15.58B | 3.90B | 392.30M | 288.10M | 1.95 |
Angiodynamic Inc Stock (ANGO) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-04-05 | Aggiornamento | Oppenheimer | Perform → Outperform |
2023-09-25 | Iniziato | H.C. Wainwright | Buy |
2023-04-17 | Downgrade | Raymond James | Strong Buy → Outperform |
2021-10-15 | Aggiornamento | Canaccord Genuity | Hold → Buy |
2021-08-20 | Iniziato | Oppenheimer | Perform |
2020-11-25 | Aggiornamento | Raymond James | Mkt Perform → Strong Buy |
2020-04-08 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
2019-04-01 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
2018-04-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
2018-01-05 | Downgrade | Craig Hallum | Buy → Hold |
2017-04-07 | Reiterato | Cantor Fitzgerald | Overweight |
2017-03-30 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
2017-02-08 | Iniziato | Barclays | Equal Weight |
2016-11-04 | Iniziato | Cantor Fitzgerald | Buy |
2016-04-08 | Ripresa | Piper Jaffray | Neutral |
2016-01-08 | Reiterato | Canaccord Genuity | Buy |
2015-11-10 | Downgrade | Raymond James | Outperform → Mkt Perform |
2015-07-24 | Iniziato | KeyBanc Capital Mkts | Overweight |
2014-06-19 | Aggiornamento | Canaccord Genuity | Hold → Buy |
2012-10-09 | Reiterato | Canaccord Genuity | Hold |
2012-06-25 | Downgrade | Canaccord Genuity | Buy → Hold |
2011-07-15 | Aggiornamento | Canaccord Genuity | Hold → Buy |
2011-07-15 | Aggiornamento | Stifel Nicolaus | Hold → Buy |
2011-06-14 | Downgrade | Wedbush | Neutral → Underperform |
2010-09-08 | Reiterato | Wedbush | Neutral |
Mostra tutto
Angiodynamic Inc Borsa (ANGO) Ultime notizie
Franklin Resources Inc. Trims Stock Position in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
JPMorgan Chase & Co. Buys 254,322 Shares of AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
Vanguard Group Inc. Buys 2,764 Shares of AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
Corebridge Financial Inc. Cuts Stock Position in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
American Century Companies Inc. Raises Stock Position in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
AngioDynamics FY2025 EPS Estimate Boosted by HC Wainwright - Defense World
AngioDynamics, Inc. (NASDAQ:ANGO) Raises Guidance - FXDailyReport.Com
AngioDynamics Stock Up on Q3 Earnings Beat, Gross Margin Expands - Yahoo Finance
AngioDynamics, Inc. (NASDAQ:ANGO) Q3 2025 Earnings Call Transcript - Insider Monkey
AngioDynamics Inc (ANGO) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
ANGIODYNAMICS INC SEC 10-Q Report - TradingView
Medical Device Maker AngioDynamics Stock Jumps On Better Than Expected Q3 Earnings, Upbeat Annual Guidance - Benzinga
Cognyte Software Posts Upbeat Results, Joins AngioDynamics, Allegiant Travel And Other Big Stocks Moving Higher On Wednesday - Benzinga
AngioDynamics Inc reports results for the quarter ended February 28Earnings Summary - TradingView
AngioDynamics Inc (ANGO) Q3 Earnings: Revenue Surpasses Estimate - GuruFocus
AngioDynamics, Inc. Revises Earnings Guidance for the Fiscal Year 2025 - MarketScreener
Uncovering Potential: AngioDynamics's Earnings Preview - Benzinga
Zacks Research Expects Lower Earnings for AngioDynamics - The AM Reporter
Charles Schwab Investment Management Inc. Purchases 2,270 Shares of AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
Bank of New York Mellon Corp Boosts Stock Position in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
AngioDynamics Doubles Down: Q3 Earnings Plus Exclusive Cardiovascular Tech Deep Dive Coming April 2 - Stock Titan
AngioDynamics, Inc. (NASDAQ:ANGO) Shares Acquired by US Bancorp DE - Defense World
Kodiak Gas Services Inc [KGS] Records 200-Day SMA of $34.01 - Knox Daily
SBI Securities Co. Ltd. Makes New $28,000 Investment in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
A Guide To The Risks Of Investing In HighPeak Energy Inc (HPK) - Knox Daily
Is Neogenomics Inc (NEO) positioned for future growth? - SETE News
AngioDynamics to Present at the Oppenheimer 35th Annual Healthcare MedTech and Services Virtual Conference - WICZ
AngioDynamics Leadership Team to Share Strategic Updates at Major Healthcare Conference - Stock Titan
Principal Financial Group Inc. Makes New Investment in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
BlackRock, Inc. Reduces Stake in AngioDynamics Inc - GuruFocus.com
Market Insight: Angiodynamic Inc (ANGO)’s Notable Drop, Closing at 11.04 - The Dwinnex
Angiodynamic Inc (ANGO) receives an Outperform rating from Oppenheimer - Knox Daily
Is it a good time to sell Palantir Technologies Inc [PLTR] shares after an insider sold 4,000 shares? - Knox Daily
Investing in CRH Plc (CRH): What You Must Know - Knox Daily
ANGO Stock Looks Promising on New Ischemia Study for Auryon System - Yahoo Finance
AngioDynamics Inc. (NASDAQ: ANGO) Reports Narrowed Net Loss and 8% Revenue Decline in Q2 FY2025 - HPBL
AngioDynamics, Inc.'s (NASDAQ:ANGO) Share Price Boosted 38% But Its Business Prospects Need A Lift Too - Simply Wall St
AngioDynamics Earnings Call Highlights Med Tech Growth - TipRanks
AngioDynamics Xcela Port Catheter Lawsuit Filed Over Infection, Need for Implant Removal - AboutLawsuits.com
With 74% institutional ownership, AngioDynamics, Inc. (NASDAQ:ANGO) is a favorite amongst the big guns - Yahoo Finance
Assenagon Asset Management S.A. Reduces Holdings in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
AngioDynamics, Inc. (NASDAQ:ANGO) Stock Position Raised by JPMorgan Chase & Co. - Defense World
Barclays PLC Boosts Position in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
AngioDynamics: Improving Financial Performance And Good Clinical Data Reinvigorate The Shares - Seeking Alpha
HC Wainwright Forecasts Strong Price Appreciation for AngioDynamics (NASDAQ:ANGO) Stock - Defense World
**AngioDynamics (NASDAQ:ANGO) Reports Fiscal Second Quarter Results** - Defense World
AngioDynamics Stock Up on Q2 Earnings Beat, Gross Margin Declines - Yahoo Finance
AngioDynamics, Inc. (NASDAQ:ANGO) Q2 2025 Earnings Call Transcript - Insider Monkey
AngioDynamics Reports Growth and Advances NanoKnife System - Yahoo Finance
Institutional investors are AngioDynamics, Inc.'s (NASDAQ:ANGO) biggest bettors and were rewarded after last week's US$154m market cap gain - Simply Wall St
AngioDynamics (NASDAQ:ANGO) Reaches New 52-Week High After Better-Than-Expected Earnings - Defense World
Angiodynamic Inc Azioni (ANGO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):